The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.

We investigated the effectiveness of lamivudine to prevent hepatitis flare up due to reactivation of hepatitis-B virus (HBV) in hepatitis-B surface antigen (HBsAg)-positive patients with Non-Hodgkin's lymphoma (NHL) during cytotoxic chemotherapy. HBsAg-positive patients with NHL were identified...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Gyeong-Won, Ryu, Min-Hee, Lee, Jae-Lyun, Oh, Sukjoong, Kim, Eunkyoung, Lee, Jae-Hwan, Kim, Seung-Bae, Kim, Sang-We, Suh, Cheolwon, Lee, Kyoo-Hyung, Kim, Woo-Kun, Lee, Jung-Shin, Kang, Yoon-Koo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Academy of Medical Sciences 2003
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055150/
https://ncbi.nlm.nih.gov/pubmed/14676442
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados